Source:http://linkedlifedata.com/resource/pubmed/id/15186949
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2004-6-9
|
pubmed:abstractText |
The presence of the apolipoprotein (Apo) e4 allele is reported to be associated with the increased risk of coronary artery disease (CAD), as well as the impairment of endothelium-dependent dilation in type 2 diabetes mellitus. Therefore, we hypothesized that the Apo e4 allele increases the death risk from coronary artery disease in type 2 diabetes. From January 1993 to December 1999, 36 type 2 diabetic patients with e4/4 or e4/3, 62 with e3/3 and 33 with e2/2 or e3/2 genotypes were recruited. All subjects were unrelated, elderly, type 2 diabetic patients with coronary artery disease, aged 60-84 years, with cardiac function at the Class I stage at time of enrollment. A follow-up study of 3-10 years was undergone. The results are as follows: At baseline, serum total cholesterol and low density lipoprotein (LDL) cholesterol concentrations were higher in subjects with e4/3 or e4/4 than in subjects with e2/2 or e3/2 (P = 0.026). Lipoprotein(a) concentration was lower in subjects with e2/2 or e3/2 than in subjects with e3/3 (P = 0.044) and e4/3 or e4/4 (P = 0.038). During the 3-10 years follow-up period, a total of 39 patients who died from CAD was recorded in this sample. Compared with patients with e3/3 (P = 0.030) and patients with e2/2 or e3/2 genotypes (P = 0.001), the mortality rate of CAD in patients with e4/3 or e4/4 genotypes was the highest (50%). Stepwise discriminant analysis revealed that in the diabetic population studied the Apo e4 allele was independently and significantly associated with CAD death (B = 0.64). However, the strength of the association decreased (B = 0.48) when total cholesterol, LDL-cholesterol and lipoprotein(a) were included in the model. Therefore, we concluded that Apo e4 allele increases the risk of CAD death in elderly patients with type 2 diabetes mellitus.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0021-9150
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
175
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
77-81
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15186949-Aged,
pubmed-meshheading:15186949-Aged, 80 and over,
pubmed-meshheading:15186949-Alleles,
pubmed-meshheading:15186949-Apolipoprotein E4,
pubmed-meshheading:15186949-Apolipoproteins E,
pubmed-meshheading:15186949-Coronary Disease,
pubmed-meshheading:15186949-Diabetes Mellitus, Type 2,
pubmed-meshheading:15186949-Endothelium, Vascular,
pubmed-meshheading:15186949-Female,
pubmed-meshheading:15186949-Genotype,
pubmed-meshheading:15186949-Humans,
pubmed-meshheading:15186949-Lipids,
pubmed-meshheading:15186949-Lipoproteins,
pubmed-meshheading:15186949-Male,
pubmed-meshheading:15186949-Middle Aged,
pubmed-meshheading:15186949-Risk Factors,
pubmed-meshheading:15186949-Vasodilation
|
pubmed:year |
2004
|
pubmed:articleTitle |
Apolipoprotein e4 allele is predictor of coronary artery disease death in elderly patients with type 2 diabetes mellitus.
|
pubmed:affiliation |
The Department of Endocrinology, Guangzhou Command Wuhan General Hospital of PLA, Wuhan 430070, PR China. guangda64@163.net
|
pubmed:publicationType |
Journal Article
|